In vivo antagonism by naloxone of morphine, beta-endorphin and a synthetic enkephalin analog
- PMID: 731437
In vivo antagonism by naloxone of morphine, beta-endorphin and a synthetic enkephalin analog
Abstract
The in vivo equivalent of pA2 values were determined in rat tail-flick and mouse hot-plate tests for naloxone against morphine, beta-endorphin and a synthetic enkephalin analog, (D-Met2,Pro5)-enkephalinamide, as analgesics. In mice the apparent pA2 value of naloxone against morphine (6.86) was similar to that found by previously and essentially the same values were obtained against the opioid peptides, indicating homogenous receptor population for the analgesics studied. In rats the pA2 of naloxone against morphine (7.17) was lower than against either beta-endorphin (7.55) or (D-Met2,Pro5)-enkephalinamide (7.51), warning that in rats such a homogeneity of the "analgesic" receptor population as was observed for mice may not exist.
Similar articles
-
Behavioral activating effects of opiates and opioid peptides.Biol Psychiatry. 1980 Feb;15(1):77-86. Biol Psychiatry. 1980. PMID: 6101965
-
Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.J Pharmacol Exp Ther. 1983 Mar;224(3):525-30. J Pharmacol Exp Ther. 1983. PMID: 6131119
-
Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide.Br J Pharmacol. 1980;71(1):201-10. doi: 10.1111/j.1476-5381.1980.tb10927.x. Br J Pharmacol. 1980. PMID: 7470736 Free PMC article.
-
Comparison of tolerance development and dependence capacities of morphine, beta-endorphin, and [D-Met2, Pro5]-enkephalinamide.Psychopharmacology (Berl). 1979 Mar 29;62(1):29-34. doi: 10.1007/BF00426031. Psychopharmacology (Berl). 1979. PMID: 108745
-
Cholecystokinin administered intrathecally selectively antagonizes intracerebroventricular beta-endorphin-induced tail-flick inhibition in the mouse.J Pharmacol Exp Ther. 1992 Mar;260(3):1086-92. J Pharmacol Exp Ther. 1992. PMID: 1545380
Cited by
-
A possible role of endogenous opioids in the control of prolactin and luteinizing-hormone secretion in the human.J Endocrinol Invest. 1981 Jan-Mar;4(1):31-6. doi: 10.1007/BF03349410. J Endocrinol Invest. 1981. PMID: 7240669
-
Slow-sustained delivery of naloxone reduces typical naloxone-induced precipitated opioid withdrawal effects in male morphine-dependent mice.J Neurosci Res. 2022 Jan;100(1):339-352. doi: 10.1002/jnr.24627. Epub 2020 Aug 8. J Neurosci Res. 2022. PMID: 32772457 Free PMC article.
-
A µ-opioid receptor modulator that works cooperatively with naloxone.Nature. 2024 Jul;631(8021):686-693. doi: 10.1038/s41586-024-07587-7. Epub 2024 Jul 3. Nature. 2024. PMID: 38961287 Free PMC article.
-
Effect of propranolol treatment in pregnant rats on motor activity and avoidance learning of the offspring.Psychopharmacology (Berl). 1983;79(2-3):148-54. doi: 10.1007/BF00427802. Psychopharmacology (Berl). 1983. PMID: 6405421
-
Species differences in the relative analgesic potencies of some classical opiates and opioid peptides.Psychopharmacology (Berl). 1984;82(4):400-2. doi: 10.1007/BF00427694. Psychopharmacology (Berl). 1984. PMID: 6328558